Recent Updates
Recently added Catalysts
REGN

Sanofi-aventis and Regeneron Report Positive Phase III Results With ZALTRAP™ (aflibercept) in Second-line Metastatic Colorectal Cancer

Tuesday, April 26, 2011 1 min read
Key Takeaway: Sanofi-aventis and Regeneron Report Positive Phase III Results With ZALTRAP™ (aflibercept) in Second-line Metastatic Colorectal Cancer

Full Press Release Details

Sanofi-aventis and Regeneron Report Positive Phase III Results With ZALTRAP™ (aflibercept) in Second-line Metastatic Colorectal Cancer.
Tags: REGN Viatris Investor Conferences Healthcare investor conferences healthcare conferences UBS Global Healthcare
Last updated: Apr 26, 2011